Metallocenes and malaria: A new therapeutic approach;Métallocènes et paludisme: Une nouvelle approche thérapeutique

Annales Pharmaceutiques Francaises

Volumn 63, Issue 4, 2005, Pages 284-294

  Pradines, B ^a   Orlandi Pradines, E ^a   Henry, M ^a   Bogreau, H ^a   Fusai, T ^a   Mosnier, J ^a   Baret, E ^a   Durand, C ^a   Bouchiba, H ^a   Penhoat, K ^a   Rogier, C ^a  

^a SERVICE DE SANTÉ DES ARMÉES   (France)

Author keywords

Antimalarial drug; Malaria; Metallocene; Metalloporphyrin; Organometallic complexes

Indexed keywords

ABC TRANSPORTER; ALUMINUM; AMINOPHENOL DERIVATIVE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; BUPARVAQUONE; CHLOROQUINE; CHLORPHENOTANE; DEFEROXAMINE; FANSIDAR; FERROCENE DERIVATIVE; FERROCENYLCHLOROQUINE; FERROQUINE; GALLIUM; GLYCOPROTEIN P; GOLD COMPLEX; HEMATIN; INSECTICIDE; IRON COMPLEX; MANGANESE; MEFLOQUINE; METAL COMPLEX; METALLOPORPHYRIN; PORPHYRIN DERIVATIVE; PROTOPORPHYRIN; RHODIUM COMPLEX; RUTHENIUM COMPLEX; THIOSEMICARBAZONE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZINC COMPLEX;

CRYSTALLIZATION; DRUG EFFICACY; DRUG POTENTIATION; DRUG RESISTANCE; DRUG STRUCTURE; GENE; GROWTH INHIBITION; MALARIA; MULTIDRUG RESISTANCE; NONHUMAN; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PLASMODIUM VINCKEI; PLASMODIUM YOELII; REVIEW;

EID: 24144445077     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4509(05)82293-X     Document Type: Article

References (73)

1. Wellems T, Plowe C. Chloroquine-resistance malaria. J Infect Dis 2001; 184: 770-6.
2. Yuthavong Y. Basis for antifolate action and resistance in malaria. Microb Infect 2002; 4: 175-82.
3. Sharma V, Piwnica-Worms D. Metal complexes for therapy and diagnosis of drug resistance. Chem Rev 1999; 99: 2545-60.
4. Wasi N, Singh HB, Gajanana, A, Raichowdhary AN. Synthesis of metal complexes of antimalarial drugs and in vitro evaluation of their activity against Plasmodium falciparum. Inorg Chim Acta 1987; 135: 133-7.
5. Sanchez-Delgado R, Navarro M, Perez H, Urbina JA. Toward a novel metal-based chemotherapy against tropical diseases. 2. Synthesis and antimalarial activity in vitro and in vivo of new ruthenium- and rhodium-chloroquine complexes. J Med Chem 1996; 39: 1095-9.
6. 6. J Med Chem 1997; 40: 1937-9.
7. Dombrowski KE, Baldwin W, Sheats JE. Metallocenes in biochemistry, microbiology and medicine. J Organ Chem 1986; 302: 292-306.
8. Ryabov AD. The biochemical reactions of organometallics with enzymes and proteins. Angew Chem Int Ed Engl 1991; 30: 931-41.
9. Biot C, Glorian G, Maciejewski LA, Brocard JS, Domarle O, Blampain G, et al. Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue. J Med Chem 1997; 40: 3715-8.
10. Biot C, Delhaes L, Abessolo H, Domarle O, Maciejewski LA, Mortuaire M, et al. Novel metallocenic compounds as anti-malarial agents. Study of the position of ferrocene in chloroquine. J Organomet Chem 1999; 589: 59-65.
11. Delhaes L, Biot C, Berry L, Delcourt P, Maciejewski LA, Camus D, et al. Synthesis of ferroquine enantiomers: first investigation of effects of metallocenic chirality upon anti-malarial activity and cytotoxicity. ChemBioChem 2002; 3: 418-23.
12. Delhaes L, Abessolo H, Biot C, Berry L, Delcourt P, Maciejewski LA, et al. In vitro and in vivo antimalarial activity of ferrochloroquine, a ferrocenyl analogue of chloroquine against chloroquine-resistant malaria parasites. Parasitol Res 2001; 87: 239-44.
13. Pradines B, Fusai T, Daries W, Laloge V, Rogier C, Millet P, et al. Ferrocene-chloroquine analogues as antimalarial agents: in vitro activity of ferrochloroquine against 103 Gabonese isolates of Plasmodium falciparum. J Antimicrob Chemother 2001; 48: 179-84.
14. Pradines B, Tall A, Rogier C, Spiegel A, Mosnier J, Marrama L, et al In vitro activities of ferrochloroquine against 55 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs. Trop Med Int Health 2002; 7: 265-70.
15. Atteke C, Mezui Me Ndong J, Aubouy A, Maciejewski L, Brocard J, Lébidi J, et al. In vitro susceptibility to a new antimalarial organometallic analogue, ferroquine, of Plasmodium falciparum isolates from the Haut-Ogooué region of Gabon. J Antimicrob Chemother 2003; 51: 1021-4.
16. Chim P, Lim P, Sem R, Nhem S, Maciejewski L, Fandeur T. The in-vitro antimalarial activity of ferrochloroquine, measured against Cambodian isolates of Plasmodium falciparum. Ann Trop Med Parasitol 2004; 98: 419-24.
17. Slater AF, Cerami A. Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites. Nature 1992; 355: 167-9.
18. Goldberg DE, Slater AF, Cerami A, Henderson GB. Hemoglobin degradation in the malaria parasite Plasmodium falciparum: an ordered process in a unique organelle. Proc Natl Acad Sci USA 1990; 87: 2931-5.
19. Basilico N, Pagani E, Monti D, Olliaro P, Taramelli D. A microtitre-based method for measuring the haem polymerisation inhibitory activity (HPIA) of antimalarial drugs. J Antimicrob Chemother 1998; 42: 55-60.
20. Vippagunta SR, Dom A, Matile H, Bhattacharjee AK, Karle JM, Ellis WY, et al. Structural specificity of chloroquine-hematin binding related to inhibition of hematin polymerisation and parasite growth. J Med Chem 1999; 42: 4630-9.
21. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell 2000; 6: 861-71.
22. Djimdé A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourté Y, et al. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med 2001; 344: 257-63.
23. Durand R, Jafari S, Vauzelle J, Delabre JF, Jesic Z, Le Bras J. Analysis of pfcrt point mutations and chloroquine susceptibility in isolates of Plasmodium falciparum. Mol Biochem Parasitol 2001; 114: 95-102.
24. Delhaes L, Biot C, Berry L, Maciejewski LA, Camus D, Brocard JS, et al. Novel ferrocenic artemisinin derivatives: synthesis, in vitro antimalarial activity and affinity of binding with ferroprotoporphyrin IX. Bioorg Med Chem 2000; 8: 2739-45.
25. Biot C, Delhaes L, Maciejewski LA, Mortuaire M, Camus D, Dive D, et al. Synthetic ferrocenic mefloquine and quinine analogues as potential antimalarial agents. Eur J Med Chem 2000; 35: 707-14.
26. Foote SJ, Thompson JK, Cowman AF, Kemp DJ. Amplification of the multidrug resistance gene in some chloroquine resistant isolates of P. falciparum. Cell 1989; 57: 921-30.
27. Cowman AF, Karcz S, Galatis D, Culvenor JG. A P-glycoprotein homologue of Plasmodium falciparum is isolated on the digestive vacuole. J Cell Biol 1991; 113: 1033-45.
28. Karcz SR, Galatis D, Cowman AF. Nucleotide binding properties of a P-glycoprotein homologue from Plasmodium falciparum. Mol Biochem Parasitol 1993; 55: 269-76.
29. Krogstad DJ, Gluzman IY, Kyle DE, Oduola AMJ, Martin SK, Milhous WK, et al. Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science 1987; 235: 1283-5.
30. (Tyr) polymorphism in Lamberene, Gabon. Parasitology 1998; 116: 211-7.
31. Van Es HHG, Renkema H, Aerts H, Schurr E. Enhanced lysosomal acidification leads to increased chloroquine accumulation in CHO cells expressing the pfmdr1 gene. Mol Biochem Parasitol 1994; 65: 209-19.
32. Goldberg DE, Sharma V, Oksman A, Gluzman IY, Wellems TE, Piwnica-Worms D. Probing the chloroquine resistance locus of Plasmodium falciparum with a novel class of multidentate metal(in) coordination complexes. J Biol Chem 1997; 272: 6567-72.
33. Harpstrite SE, Beatty AA, Collins SD, Oksman A, Goldberg DE, Sharma V. Metalloantimalarials: targeting of P. falciparum strains with novel iron(III) and gallium(ni) complexes of an amine phenol ligand. Inorg Chem 2003; 42: 2294-300.
34. Pagola S, Stephens PW, Bohle DS, Kosar AD, Madsen SK. The structure of malaria pigment β-haematin. Nature 2000; 404: 307-10.
35. Dorn A, Vippagunta SR, Matile H, Jaquet C, Vennerstrom JL, Ridley RG. An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerization by quinoline antimalarials. Biochem Pharmacol 1998; 55: 727-36.
36. Hawley SR, Bray PG, Mungthin M, Atkinson JD, O'Neill PM, Ward SA. Relationship between antimalarial drug activity, accumulation, and inhibition of heme polymerisation in Plasmodium falciparum in vitro. Antimicrob Agents Chemother 1998; 42: 682-6.
37. Orjih AU. Haemolysis of Plasmodium falciparum trophozoite-infected erythrocytes after artemisinin exposure. Br J Haematol 1996; 92: 324-8.
38. Pandey AV, Tekwani BL, Singh RL, Chauban VS. Artemisinin, an endoperoxyde antimalarial, disrupt the hemoglobin catabolism and heme detoxification system in malarial parasite. J Biol Chem 1999; 274: 19383-8.
39. Sharma V, Crankshaw CL, Piwnica-Worms D. Effects of multidrug resistance (MDR1) P-glycoprotein expression levels and coordination metal on the cytotoxic potency of multidentate (N4O2) (ethylenediamine)bis[propyl(R-benzylimino)] metal (III) cations. J Med Chem 1996; 39: 3483-90.
40. Ocheskey JA, Polyakov VR, Harpstrite SE, Oksman A, Goldberg DE, Piwnica-Worms D, et al. Synthesis, characterization, and molecular structure of a gallium (IU) complex of an amine-phenol ligand with activity against chloroquine-sensitive Plasmodium falciparum strains. J Inorg Biochem 2003; 93: 265-70.
41. Gokhale NH, Padhye SB, Croft SL, Kendrick HD, Davies W, Anson CE, et al. Transition metal complexes of buparvaquone as potent new antimalarial agents. 1. Synthesis, X-ray crystal-structures, electrochemistry and antimalarial activity against Plasmodium falciparum. J Inorg Biochem 2003; 95: 249-58.
42. Offiong OE, Martelli S. Synthesis and biological activity of novel metal complexes of 2-acetylpyridine thiosemicarbazones. Il Farmaco 1995; 50: 625-32.
43. Offiong OE, Etok C, Martelli S. Synthesis and biological activity of platinum group metal complexes of o-vanillin thiosemicarbazones. Il Farmaco 1996; 51: 801-8.
44. Itoh T, Shirakami S, Ishida N, Yamashita Y, Yoshida T, Kim HS, et al. Synthesis of novel ferrocenyl sugars and their anti-malarial activities. Bioorg Med Chem Lett 2000; 10: 1657-9.
45. Chevion M, Chuang L, Golenser J. Effects of zinc-desferrioxamine on Plasmodium falciparum in culture. Antimicrob Agents Chemother 1995; 39: 1902-5.
46. Scott MD, Ranz A, Kuypers FA, Lubin BH, Meschnick SR. Parasite uptake of desferrioxamine: a prerequisite for anti-malarial activity. Br J Haematol 1990; 75: 598-603.
47. Loyevsky M, Lytton SD, Mester B, Libman J, Shanzer A, Cabantchik ZI. The antimalarial action of Desferal involves a direct access route to erythrocytic (Plasmodium falciparum) parasites. J Clin Invest 1993; 91: 218-24.
48. Raventos-Suarez C, Pollack S, Nagel RL. Plasmodium falciparum: inhibition of in vitro growth by desferrioxamine. Am J Trop Med Hyg 1982; 31: 919-22.
49. Heppner DG, Hallaway PE, Kontoghiorghes GJ, Eaton JW. Antimalarial properties of orally active iron chelators. Blood 1988; 72: 358-61.
50. Whitehead S, Peto TE. Stage-dependent effect of deferoxamine on growth of Plasmodium falciparum in vitro. Blood 1990; 76: 1250-5.
51. Pradines B, Millet J, Henry M. Chélation du fer dans la thérapie antipaludique. Med Trop 2003; 63: 119-30.
52. Ginsburg H, Famin O, Zhang J, Krugliak M. Inhibition of glutathione-dependent degradation of heme by chloroquine and amodiaquine as possible basis for their antimalarial mode of action. Biochem Pharmacol 1998; 56: 1305-13.
53. Francis SE, Sullivan DJ, Goldberg DE. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu Rev Microbiol 1997; 51: 97-123.
54. Goldberg DE, Slater AFG, Cerami A, Henderson GB. Hemoglobin degradation in the malaria parasite Plasmodium falciparum: an ordered process in a unique organelle. Proc Natl Acad Sci USA 1990; 87: 2931-5.
55. Slater AFG, Swiggard WJ, Orton BR, Flitter WO, Goldberg DE, Cerami A, et al. An iron-carboxylate bond links the heme units of malaria pigment. Proc Natl Acad Sci USA 1991; 88: 325-9.
56. Chou AC, Chevli R, Fitch CD. Ferriprotoporphyrin IX fulfils the criteria for identification as the chloroquine receptor of malaria parasites. Biochem 1980; 19: 1543-9.
57. Egan TJ, Ross DC, Adams PA. Quinoline antimalarial drugs inhibit spontaneous formation of β-haematin (malaria pigment). FEBS Lett 1994; 352: 54-7.
58. Martiney JA, Cerami A, Slater AFG. Inhibition of hemozoin formation in Plasmodium falciparum trophozoite extracts by heme analogs: possible implication in the resistance to malaria conferred by the β-thalassemia trait. Mol Med 1996; 2: 236-46.
59. Basilico N, Monti D, Olliaro P, Taramelli D. Non-iron porphyrins inhibit β-haematin (malaria pigment) polymerisation. FEBS Lett 1997; 409: 297-9.
60. Monti D, Vodopivec B, Basilico N, Olliaro P, Taramelli D. A novel endogenous antimalarial: Fe(II)-protoporphyrin IX α (heme) inhibits hematin polymerization to β-hematin (malaria pigment) and kills malaria parasites. Biochem 1999; 38: 8858-63.
61. Cole KA, Ziegler J, Evans CA, Wright DW. Metalloporphyrins inhibit β-hematin (hemozoin) formation. J Inorg Biochem 2000; 78: 109-15.
62. Benoit-Vical F, Robert A, Meunier B. Potentiation of artemisinin activity against chloroquine-resistant Plasmodium falciparum strains by using heme models. Antimicrob Agents Chemother 1999; 43: 2555-8.
63. Benoit-Vical F, Robert A, Meunier B. In vitro and in vivo potentiation of artemisinin and synthetic endoperoxide antimalarial drugs by metalloporphyrins. Antimicrob Agents Chemother 2000; 44: 2836-41.
64. Begum K, Kim HS, Kumar V, Stojiljkovic I, Wataya Y. In vitro antimalarial activity of metalloporphyrins against Plasmodium falciparum. Parasitol Res 2003; 90: 221-4.
65. Meshnick SR. Artemisin antimalarials: mechanisms of action and resistance. Med Trop 1998; 58: 13-7.
66. Olliaro P, Haynes RK, Meunier B, Yuthavong Y. Possible modes of action of the artemisinin-type compounds. TRENDS Parasitol 2001; 17: 122-6.
67. Cumming JN, Ploypradith P, Posner G. Antimalarial activity of artemisinin (qinghaosu) and related trioxanes: mechanisms of action. Adv Pharmacol 1997; 37: 253-97.
68. Asawamahsakda W, Ittarat I, Pu YM, Ziffer H, Meschnick SR. Reaction of antimalarial endoperoxides with specific parasite proteins. Antimicrob Agents Chemother 1994; 38: 1854-8.
69. Yang YZ, Little B, Meshnick SR. Alkylation of proteins by artemisinin. Biochem Pharmacol 1994; 48: 569-74.
70. Paitayatat S, Tarnchompoo B, Thebtaranonth Y, Yuthavong Y. Correlation of antimalarial activity of artemisinin derivatives with binding affinity with ferroprotoporphyrine IX. J Med Chem 1997; 40: 633-8.
71. Meshnick SR, Thomas A, Ranz A, Xu CM, Pan HZ. Artemisinin (qinghaosu): the role of intracellular hemin in its mechanism of antimalarial action. Mol Biochem Parasitol 1991; 49: 181-9.
72. Wei N, Sadrzadeh SMH. Enhancement of hemin-induced membrane damage by artemisinin. Biochem Pharmacol 1994; 48: 737-41.
73. Shukla K, Gund TM, Meshnick SR. Molecular modeling studies of the artemisinin-hemin interaction: docking between the antimalarial agent and its putative receptor. J Mol Graphics 1995; 13: 215-22.